Skip to main content
. 2010 Sep 15;11(1):190–200. doi: 10.1016/j.meegid.2010.09.002

Table 2.

Serological and virus recovery results post-challenge with ck/CH/LAH/08II and ck/CH/LHB/08I.

Group a Vaccinated Challenged Dose, median embryo infectious doses (log 10)b Morbidity Mortality Antibodyc
Virus recoveryd
Days post vaccination
Days post challenge
Trachea Kidney Lung Caecal tonsil
4 8 12 16 3 6 9 12 16
1 Yes Yes, with ck/CH/LAH/08II 5.0 0/10 0/10 0/10 2/10 9/10 10/10 10/10 10/10 10/10 10/10 10/10 4/10 2/10 2/10 4/10
2 No Yes, with ck/CH/LAH/08II 5.0 10/10 1/10 0/10 0/10 0/10 0/10 0/10 0/9 9/9 9/9 9/9 8/10 4/10 5/10 8/10
3 Yes Yes, with ck/CH/LHB/08I 5.0 10/10 3/10 0/10 4/10 10/10 10/10 10/10 9/9 8/8 7/7 7/7 10/10 3/10 1/10 6/10
4 No Yes, with ck/CH/LHB/08I 5.0 10/10 7/10 0/10 0/10 0/10 0/10 0/10 5/9 4/5 4/4 3/3 10/10 10/10 6/10 10/10
5 No No 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10
a

Twenty chicks per group.

b

Dose per chick (ck/CH/LAH/08II and ck/CH/LHB/08I), 100 μl.

c

Number seroconverted/number inoculated.

d

Two procedures were used for virus recovery after challenge. First, lesions in embryos that had been inoculated with individual trachea or kidney tissue samples were observed. Second, RT-PCR using oligonucleotide primers N(+) and N(−) on RNA from the allantoic fluid of the same eggs was conducted. The results from the two procedures were identical. Data are number of chicks that showed positive results after challenge/number of chicks that survived after challenge.